Three Stocks Nobody's Talking About That Are Quietly Printing Money: ARLO, HIMS, and CRVL

Everyone's arguing about $SNDK crashing 14% and whether Tesla's delivery beat was priced in. Meanwhile, three names nobody's watching are quietly doing the work.

First up: $HIMS (Hims & Hers Health, ~$3B market cap). The underground peptide market Bloomberg Podcasts called a "$1-3 billion black market going mainstream" is essentially a free catalyst waiting to land in HIMS's lap. An FDA advisory committee is expected to recommend legalizing 7 peptides for compounding — and HIMS is already one of the largest compounding pharmacy platforms in the US. When that ruling drops, the addressable market expands overnight. Second: $ARLO (Arlo Technologies, ~$800M market cap). With AI increasingly embedded in home security and the healthcare-AI wave (per Investor's Business Daily) spilling into consumer IoT, Arlo's subscription model and recent profitability inflection make it an acquisition target hiding in plain sight. Third: $CRVL (CorVel, ~$3.5B market cap) — a workers' comp managed care play benefiting from AI-driven claims processing, sitting at record highs with zero analyst fanfare.

The crowd is looking left at chipmakers. These three are the right turn.